Literature DB >> 12453074

Measuring fatigue in patients with Parkinson's disease - the Fatigue Severity Scale.

K Herlofson1, J P Larsen.   

Abstract

The objective was to compare the prevalence and severity of fatigue in patients with Parkinson's disease (PD) with that in two control groups, one consisting of randomly chosen control subjects of the same age and sex distribution and the other consisting of patients with coxarthrosis waiting to receive total hip replacement. We also explored the possible correlation of demographic and clinical data to the presence and severity of fatigue. Sixty-six patients with PD, 131 randomly chosen controls and 79 patients with coxarthrosis, waiting to receive total hip replacement, were evaluated for fatigue. Patients and controls with a depressive mood disorder or cognitive impairment had been excluded from the study. Fatigue was measured by the Fatigue Severity Scale (FSS). For the patients with PD the mean total FSS score was 4.1, compared with 2.7 amongst the randomly chosen control group and 2.9 in the group consisting of patients with coxarthrosis. Fifty per cent of the patients with PD had a mean total FSS score of 4 or higher, compared with 25% in both of the two control groups. There was no correlation between pain, presence of self-reported nocturnal sleep disorders or duration of PD and fatigue. The patients with fatigue did have a more advanced disease, measured both by Unified Parkinson's Disease Rating Scale score and Hoehn and Yahr stage. Although the univariate analyses indicated that more severe parkinsonism was correlated to the symptom, the multivariate analysis showed that none of the studied variables were significant explanatory factors for fatigue. Fatigue is a common symptom in patients with PD without depression or dementia. The study indicates that fatigue is an independent symptom of the disease without relation to other motor or non-motor symptoms.

Entities:  

Mesh:

Year:  2002        PMID: 12453074     DOI: 10.1046/j.1468-1331.2002.00444.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  38 in total

1.  Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS).

Authors:  Pablo Martinez-Martin; Maria Jose Catalan; Julian Benito-Leon; Angel Ortega Moreno; Ivana Zamarbide; Esther Cubo; Nadeje van Blercon; Victor Campos Arillo; Margarita Pondal; Gurutz Linazasoro; Fernando Alonso; Pedro García Ruiz; Belen Frades
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

2.  Fatigue in levodopa-naive subjects with Parkinson disease.

Authors:  G Schifitto; J H Friedman; D Oakes; L Shulman; C L Comella; K Marek; S Fahn
Journal:  Neurology       Date:  2008-08-12       Impact factor: 9.910

3.  Cross-cultural adaptation and psychometric evaluations of the Turkish version of Parkinson Fatigue Scale.

Authors:  Erhan Arif Ozturk; Bilge Gonenli Kocer; Ebru Umay; Aytul Cakci
Journal:  Qual Life Res       Date:  2018-06-07       Impact factor: 4.147

4.  Modafinil for Parkinson's disease fatigue.

Authors:  Hilary L Tyne; Joanne Taylor; Gus A Baker; Malcolm J Steiger
Journal:  J Neurol       Date:  2009-10-20       Impact factor: 4.849

5.  Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease.

Authors:  Neil A Kelly; Matthew P Ford; David G Standaert; Ray L Watts; C Scott Bickel; Douglas R Moellering; S Craig Tuggle; Jeri Y Williams; Laura Lieb; Samuel T Windham; Marcas M Bamman
Journal:  J Appl Physiol (1985)       Date:  2014-01-09

6.  Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia.

Authors:  Asli Gencay-Can; Serdar Suleyman Can
Journal:  Rheumatol Int       Date:  2010-07-24       Impact factor: 2.631

7.  Fatigue: an important feature of late-onset Pompe disease.

Authors:  Marloes L C Hagemans; Sabine P M van Schie; A Cecile J W Janssens; Pieter A van Doorn; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

Review 8.  Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease.

Authors:  J M de Vries; M L C Hagemans; J B J Bussmann; A T van der Ploeg; P A van Doorn
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

9.  Measuring fatigue in persons with spinal cord injury.

Authors:  Hubert A Anton; William C Miller; Andrea F Townson
Journal:  Arch Phys Med Rehabil       Date:  2008-03       Impact factor: 3.966

10.  Relationship Between Walking Capacity, Biopsychosocial Factors, Self-efficacy, and Walking Activity in Persons Poststroke.

Authors:  Kelly A Danks; Ryan T Pohlig; Margie Roos; Tamara R Wright; Darcy S Reisman
Journal:  J Neurol Phys Ther       Date:  2016-10       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.